Drawing for THE INSIDES

USPTO serial 79294155

THE INSIDES

Reviewed by CopyMark Law Group

Reg. 6495567Status 700Renewal
Filing date
Status date
Registration date
Sep 28, 2021
Examiner
FALK, JONATHAN ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with THE INSIDES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Surgical apparatus and instruments and medical apparatus and instruments for use in surgery; surgical devices for use in drug delivery, namely syringes, hypodermic needles, catheters and cannulas for use in drug delivery; external and implantable medical devices, namely prosthetic devices in the nature of artificial gastrointestinal implants, diagnostic medical devices for diagnosing gastrointestinal disorders and diseases, and devices to control the fluid in and out of stoma; Medical instruments, devices and apparatus for use in diagnostic testing of the gastrointestinal tract; medical devices for use in treating or diagnosing functional gastrointestinal disorders; gastrointestinal implants composed of artificial materials; medical instruments for delivery and retrieval of gastrointestinal implants; medical apparatus, namely, systems for delivery and retrieval of gastrointestinal implants; surgical devices for use with patients with colorectal cancer and other gastrointestinal diseases; surgical implants comprised of artificial materials; surgical instruments and apparatus; medical instruments for interstitial thermotherapy of biological tissue; prosthetic artificial gastrointestinal implants and implants for use in urostomies; medical implants comprised of artificial materials; intravascular implants made from artificial materials; medical devices for placing and securing catheters; catheters; medical devices for use in treating or diagnosing rectal cancer, colon cancer, polyps, fistulas, high output ileostomies, high output fistulas; medical devices to assist in trans-anal surgery; medical devices for intestinal re-feeding; medical devices for intestinal drug deployment, sold empty; medical devices for use in treating or diagnosing gastrointestinal diseaseACTIVE
042Providing a platform-as-a-service (PaaS) featuring computer software platforms to enable patients and health care providers to interact remotely, health care providers to access and manage patient medical data, patients to receive information and advertising related to their health care, and patients and clinicians to purchase health care products, for digital health care purposes; and medical research services and scientific laboratory services for acquiring, testing and screening data within the framework of continuous health monitoringACTIVE
044Medical services and surgical services, namely gastrointestinal surgery, gynaecological surgery, colorectal surgery and endoscopies of the gastrointestinal tract; Medical and surgical diagnostic testing, monitoring and reporting services; fitting of prosthetics; medical diagnostic testing, monitoring and reporting services in the fields of medicine related to the gastrointestinal tract; DNA screening for medical purposes, namely, medical DNA and genetic testing for the diagnosis of conditions of the gastrointestinal tract; medical diagnostic testing and reporting services for conditions of the gastrointestinal tract; Collection of human cell or tissue samples for the medical diagnosis of conditions of the gastrointestinal tract; remote patient monitoring services to assist medical professionals in providing medical diagnosis and treatment; medical services, namely, monitoring of losses of intestinal fluid from enterostomies; medical services, namely, monitoring of patient adherence to intestinal re-feeding; medical services, namely, intestinal drug delivery services; medical services, namely, intestinal probiotic delivery services; medical services, namely, intestinal microbiome monitoringACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 4, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 16, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Mar 16, 2022FIMPFINAL DISPOSITION PROCESSED
Dec 28, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 28, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2021GPNXNOTIFICATION PROCESSED BY IB
Jul 13, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 13, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 30, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 23, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 31, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 23, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Apr 23, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 23, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 13, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2020RFNTREFUSAL PROCESSED BY IB
Nov 27, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 27, 2020RFRRREFUSAL PROCESSED BY MPU
Nov 7, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 6, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2020DOCKASSIGNED TO EXAMINER
Oct 2, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Sep 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance